French vaccine maker Valneva is cutting as much as 15% of its workforce and reducing revenue projections as reduced travel erodes demand for vaccines.
May 13, 2026 01:46 PM EDT
Valneva to cut up to 15% of jobs as reduced travel hits vaccine demand
French vaccine maker Valneva is laying off 10% to 15% of its workforce and reducing revenue projections due to “an emerging adverse trend in travel …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Think we're worth reading - tell Google.
In a memo to employees, Moderna CEO Stephane Bancel said the company expects to have fewer than 5,000 workers by the end of the…
Novo Nordisk, which produces Wegovy and Ozempic, said roughly 9,000 roles would be cut, with 5,000 of these reductions expected…
Moderna said Thursday it plans to reduce the size of its workforce by 10% globally.
The Wegovy obesity drug maker on Wednesday announced plans to trim 11.5% of its workforce.
At a time when many newsrooms are shrinking, your support is more important than ever. Membership ensures we can keep covering…
The layoffs come amid sluggish sales as competition heats up in the weight-loss drug market.
